EMENS LEISHA A ET AL: "Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.", JOURNAL OF CLINICAL ONCOLOGY : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY 10 DEC 2009, vol. 27, no. 35, 10 December 2009 (2009-12-10), pages 5911-5918, ISSN: 1527-7755 (B1)

GREENWALD R J ET AL: "Negative co-receptors on lymphocytes", CURRENT OPINION IN IMMUNOLOGY, ELSEVIER, OXFORD, GB, vol. 14, no. 3, 1 June 2002 (2002-06-01), pages 391-396, XP004350492, ISSN: 0952-7915 (B1)

OZKAYNAK E ET AL: "Programmed Death-1 Targeting Can Promote Allograft Survival", JOURNAL OF IMMUNOLOGY, AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 169, 1 January 2002 (2002-01-01), pages 6546-6553, XP002980100, ISSN: 0022-1767 (B1)

TSENG SU-YI ET AL: "B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, UNITED STATES, vol. 193, no. 7, 2 April 2001 (2001-04-02) , pages 839-845, XP002189416, ISSN: 0022-1007 (B1)

US-A1- 2002 091 246 (B1)

US-A1- 2006 159 685 (B1)

YOUNGNAK P ET AL: "Differential binding properties of B7-H1 and B7-DC to programmed death-1", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 307, no. 3, 1 August 2003 (2003-08-01), pages 672-677, XP004441481, ISSN: 0006-291X, DOI: 10.1016/S0006-291X(03)01257-9 (B1)

US-A1- 2007 231 344 (B1)

WADA SATOSHI ET AL: "Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.", CANCER RESEARCH 15 MAY 2009, vol. 69, no. 10, 15 May 2009 (2009-05-15), pages 4309-4318, ISSN: 1538-7445 (B1)

WO-A1-93/08120 (B1)

WO-A2-01/94413 (B1)

WO-A2-03/020259 (B1)

US-A1- 2006 292 593 (B1)